Industry2h ago
Isomorphic Labs Raises $2.1 Billion For Drug Design
Isomorphic Labs raised $2.1 billion to scale its AI-driven drug discovery engine. The Google DeepMind spinoff partnered with Novartis and Eli Lilly to identify hidden drug targets. This move leverages protein structure prediction to bypass traditional discovery bottlenecks. Practitioners should watch for the first clinical successes from these specific partnerships.